Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 45 (5), 705-711
- https://doi.org/10.1016/j.jacc.2004.06.080
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, MinnesotaJournal of the American College of Cardiology, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summaryJournal of the American College of Cardiology, 2001
- Characteristics of 9194 Patients With Left Ventricular HypertrophyHypertension, 1998
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998
- H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension studyAmerican Journal of Hypertension, 1997
- The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up studyAmerican Journal Of Medicine, 1995
- Epidemiology of hypertensionThe Lancet, 1994
- An updated coronary risk profile. A statement for health professionals.Circulation, 1991